To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

825.15a day ago
843.30a day ago
arrow

LOWER/UPPER CIRCUITS

667.65
1,001.45
arrow
Jubilant Ingrevia Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 1.06%, in the last year to ₹4,215.43 Cr. Its sector's average revenue growth for the last fiscal year was 7.61%.
noteAnnual Net Profit,rose 37.34% in the last year to ₹251.17 Cr. Its sector's average net profit growth for the last fiscal year was 33.32%.
notePrice to Earning Ratio,is 52.71, lower than its sector PE ratio of 53.62.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %
Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. Jubilant Ingrevia is the demerged pharma and life sciences business of Jubilant Lifesciences and listed on the exchanges in FY21.
personal

Grow your wealth with more research recommendations

+91